Longboard Pharmaceuticals Reports Improved EPS for Fiscal Year 2023
Longboard Pharmaceuticals has reported an EPS of $(2.39) for the fiscal year 2023, which marks an improvement from $(2.56) year ...
Longboard Pharmaceuticals has reported an EPS of $(2.39) for the fiscal year 2023, which marks an improvement from $(2.56) year ...
On March 11, 2024, KKR announced its acquisition of mdf commerce for C$255 million, offering shareholders C$5.80 per share in ...
As of February 5, 2024, KKR & Co (NYSE: KKR) has shown an impressive average annual return of approximately 13.82% ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.